Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Taylor Ben R. Director active across 1 company, notably Recursion Pharmaceuticals, INC.. Aggregated, 7 disclosures have been published. Activity tracked since 16 December 2024. The latest transaction was filed on 15 May 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
11,908 shares@ US$4.2510.9% of flowClass A Common StockSEC:0001601830-25-000083:0
26,571 shares@ US$5.09530.2% of flowClass A Common StockSEC:0001601830-25-000057:0
7,057 shares@ US$6.8410.7% of flowClass A Common StockSEC:0001601830-25-000049:0
10,879 shares@ US$10.6426.6% of flowClass A Common StockSEC:0001601830-25-000019:0
35,018 shares0Class A Common StockSEC:0001628280-25-004088:0
370,343 shares0Class A Common StockSEC:0001601830-24-000249:0
15,668 shares@ US$6.0421.7% of flowClass A Common StockSEC:0001601830-24-000247:0